Skip Ribbon Commands
Skip to main content

News

 

 

Terumo expands global presence with new subsidiary in South-Africahttps://www.terumo-europe.com/en-emea/news/terumo-expands-global-presence-with-new-subsidiary-in-south-africaTerumo expands global presence with new subsidiary in South-Africa11/29/2023 11:00:00 PM<p>Terumo Corporation (TSE: 4543) today announced the establishment of Terumo South Africa (Pty) Ltd. (Terumo South Africa), its newest subsidiary in South-Africa. This strategic move represents a significant milestone in the company’s continued commitment to expanding its global footprint and strengthening its presence in key growing markets.​<br></p>
Terumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Companyhttps://www.terumo-europe.com/en-emea/news/terumo-to-construct-a-new-manufacturing-facility-at-its-kofu-factory-for-the-medical-care-solutions-companyTerumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company5/14/2023 10:00:00 PM<p>52.2 Billion JPY Capital Investment to Strengthen the Production Capability to Meet the Growing Global Demands​<br></p>
Ultimaster Nagomi™ MDR certification and launch of large-scale post-market study investigating the new coronary stent system in complex PCIhttps://www.terumo-europe.com/en-emea/news/ultimaster-nagomi™-mdr-certification-and-launch-of-large-scale-post-market-study-investigating-the-new-coronary-stent-systeUltimaster Nagomi™ MDR certification and launch of large-scale post-market study investigating the new coronary stent system in complex PCI4/25/2023 10:00:00 PM<p></p>​First patient enrolled in the NAGOMI COMPLEX PMCF study <br>
Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Alignedhttps://www.terumo-europe.com/en-emea/news/terumo-group’s-targets-for-greenhouse-gas-reduction-approved-by-the-sbt-initiative-as-1-5°c-alignedTerumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned4/23/2023 10:00:00 PM<p>Terumo Corporation (TSE: 4543) today announced that its greenhouse gas (GHG) emissions reduction targets have been approved by the Science Based Targets initiative (SBTi) as being aligned with the common goal to limit global temperature rise to 1.5°C above pre-industrial levels.​​<br></p>
Ultimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in Francehttps://www.terumo-europe.com/en-emea/news/ultimaster-drug-eluting-stent-family-first-stent-to-receive-the-mention-1-month-dapt-in-the-reimbursement-conditions-in-frUltimaster Drug Eluting Stent family (Terumo) first stent to receive the mention 1-month DAPT in the reimbursement conditions in France12/7/2022 11:00:00 PM<h4>​Terumo Europe is proud to announce that the HAS (Haute Autorité de Santé) in France has acknowledged in an evidence-based assessment that for the <strong>Ultimaster</strong><sup><strong>TM</strong></sup> and <strong>Ultimaster</strong><sup><strong>TM</strong></sup> <strong>Tansei</strong><sup><strong>TM</strong></sup> stents dual antiplatelet therapy (DAPT) can safely be stopped <strong>after 1 month for High Bleeding Risk patients</strong>. This conclusion is based on the strong and unmatched clinical data generated in the MASTER DAPT study and hence superiority of shortened DAPT regimen can only be attributable and linked to the <strong>Ultimaster</strong><sup><strong>TM</strong></sup> stent.<br><br></h4>
Terumo Pharmaceutical Solutions hosts successful customer collaboration event in South Koreahttps://www.terumo-europe.com/en-emea/news/terumo-pharmaceutical-solutions-hosts-successful-customer-collaboration-event-in-south-koreaTerumo Pharmaceutical Solutions hosts successful customer collaboration event in South Korea11/21/2022 11:00:00 PM<h4>​Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of primary container, injection, infusion therapy devices, and contract development and manufacturing services (CDMO) hosted a successful collaboration customer event in South Korea.<br></h4>